ERYTHEMA
Clinical trials for ERYTHEMA explained in plain language.
Never miss a new study
Get alerted when new ERYTHEMA trials appear
Sign up with your email to follow new studies for ERYTHEMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for aggressive breast cancer: targeted combo before surgery
Disease control OngoingThis study tests whether adding the drug panitumumab to standard chemotherapy helps shrink tumors more effectively in people with a rare and aggressive type of breast cancer called triple-negative inflammatory breast cancer. About 42 participants will receive chemotherapy before …
Matched conditions: ERYTHEMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Immunotherapy shows promise in controlling advanced breast cancer after chemo
Disease control OngoingThis study tested the drug pembrolizumab in 71 people with advanced inflammatory or triple-negative breast cancer that had spread or returned. Participants had already responded to chemotherapy. The goal was to see if pembrolizumab could keep the cancer from growing for at least …
Matched conditions: ERYTHEMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC